CSI Market
Sign In | Register

Mimedx Group Inc (MDXG) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access MDXG quarterly Cash Flow →
A period-by-period view of cash flow from Mimedx Group Inc to Dec 31 2021 helps clarify how Dec 31 2025's cash position has changed over time.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
12 Months 		(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Operating Activities
Income48.58
Depreciation & amortization14.88
Amortization of Other Assets0.00
Asset Retirement Obligation, Accretion Expense0.00
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability0.00
Provision For Loan Losses Expensed6.52
Increase (Decrease) in Inventories-1.53
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Property Plant Equipment0.00
Share-based Compensation16.40
Income (Loss) from Equity Method Investments0.00
Gains (Losses) on Extinguishment of Debt0.00
Other Share Based Compensation Expense-
Change In Fair Value Of Earn Out Liability-
Stock Issued During Period Value For Accrued Director Fees-
Stock Issued During Period Shares For Accrued Director Fees-
Stock Issued During Period Shares Cashless Exercise Of Warrants-
Impairment Of Intangible Assets-
Other Share- Based Compensation Expense-
Gain Loss On Disposition Of Property-
Impairment of Intangible Assets-
Operating Lease Rightofuse Asset Amortization-
New Accounting Pronouncement Or Change In Accounting Principle Effect Of Adoption Quantification-
Operating Lease Right Of Use Asset Amortization Expense1.26
Amortization Of Intangible Assets Cost Of Sales And Operating Expenses-
Income taxes0.64
Losses/ -gains on Investments net0.00
Accounts Receivable-17.41
Increase (Decrease) in Accounts Payable2.12
Increase (Decrease) in Accrued Liabilities2.37
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Deferred Income Taxes8.71
Other Working Capital-8.53
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities0.00
Discontinued operations0.00
Net Cash flow from Operating Activities74.00
Investing Activities
Capital Expenditures-1.03
Sale of Capital Items0.00
Proceeds from Sale and Maturity of Held-to-maturity Securities0.00
Payments to Acquire Marketable Securities0.00
Real Estate Investments0.00
Proceeds From Reba Grant-
Payments for Application Costs Patent-
Payments For Application Costs Patent-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments to Acquire Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire Businesses, Gross-3.76
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Proceeds from Collection of Notes Receivable0.00
Payments for (Proceeds from) Other Investing Activities-2.09
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-6.89
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.00
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-4.41
Proceeds From Line Of Credit With Related Party-
Proceeds from Issuance of Temporary Equity-
Finance Lease Principal Payments-
Principal Payments Of Secured Debt-1.00
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities-5.41
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow72.97
Total Cash Flow61.71
4 historic quarters locked

Sign in to unlock the full Mimedx Group Inc cash flow history.

Sign In Create Free Account

About Mimedx Group Inc Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-K filings and normalized by CSIMarket.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: February 25, 2026
  • Source: mdxg-20251231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001376339-26-000011

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document 





                    


    



  Get the full CSIMarket dataset:
  Subscribe
  API
  License